Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Head and Neck Cancers

Condition:   Head and Neck Squamous Cell Carcinoma
Interventions:   Drug: Docetaxel;   Drug: Cisplatinum;   Radiation: IMRT
Sponsors:   Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University;   Fudan University
Not yet recruiting - verified October 2016

http://ift.tt/2cQ0K5a